Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROPEGINTERFERON ALFA-2B-NJFT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROPEGINTERFERON ALFA-2B-NJFT: Safety Overview

Metric ROLAPITANT ROPEGINTERFERON ALFA-2B-NJFT
Total FAERS Reports 873 1,405
Deaths Reported 252 17
Death Rate 28.9% 1.2%
Hospitalizations 155 119
Average Patient Age 61.4 yrs 51.6 yrs
% Female Patients 57.5% 60.0%
FDA Approval Date Oct 25, 2017 N/A
Manufacturer TerSera Therapeutics LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription